These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7685518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
    Grever M, Leiby J, Kraut E, Metz E, Neidhart J, Balcerzak S, Malspeis L.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):39-48. PubMed ID: 1699282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Oct; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 11. Fludarabine phosphate: a new active agent in hematologic malignancies.
    Keating MJ, O'Brien S, Plunkett W, Robertson LE, Gandhi V, Estey E, Dimopoulos M, Cabanillas F, Kemena A, Kantarjian H.
    Semin Hematol; 1994 Jan; 31(1):28-39. PubMed ID: 7510070
    [No Abstract] [Full Text] [Related]

  • 12. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM, Redman JR, Keating MJ.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Yang LY, Gandhi V.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [Abstract] [Full Text] [Related]

  • 15. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 16. Phase I clinical trials with fludarabine phosphate.
    Von Hoff DD.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.